B3galt2 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2
GeneMGI:1349461
Physiological systems
18 / 24 physiological systems tested
6 Significantly impacted by the knock-out
Immune system Hematopoietic system Behavior/neurological Skeleton Mortality/aging Renal/urinary system
12 No significant impact
6 Not tested
Data collections
Gene metrics:7Significant phenotypes
0Associated diseases
Expression examined in:0Adult tissues
0Embryo tissues
| hyperactivity | 4 supporting datasets | B3galt2tm1.1(KOMP)Vlcg | heterozygote | Early adult | 1.4x10-5 | ||
| preweaning lethality, incomplete penetrance | 2 supporting datasets | B3galt2tm1.1(KOMP)Vlcg | homozygote | Early adult | N/A * | ||
| increased bone mineral content | 1 supporting dataset | B3galt2tm1.1(KOMP)Vlcg | heterozygote | Early adult | 6.59x10-5 | ||
| abnormal kidney morphology | 1 supporting dataset | B3galt2tm1.1(KOMP)Vlcg | heterozygote | Early adult | N/A * | ||
| small kidney | 1 supporting dataset | B3galt2tm1.1(KOMP)Vlcg | heterozygote | Early adult | N/A * | ||
| decreased lymphocyte cell number | 1 supporting dataset | B3galt2tm1.1(KOMP)Vlcg | heterozygote | Early adult | 7.51x10-5 | ||
| increased bone mineral density | 1 supporting dataset | B3galt2tm1.1(KOMP)Vlcg | heterozygote | Early adult | 7.58x10-5 |
| | | | | | | | | | |
External links
No external links available for B3galt2.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.